RGD DISEASE ONTOLOGY - ANNOTATIONS
RGD uses the Human Disease Ontology (DO, https://disease-ontology.org/) for disease curation across species. RGD automatically downloads each new release of the ontology on a monthly basis. Some additional terms which are required for RGD's curation purposes but are not currently covered in the official version of DO have been added. As corresponding terms are added to DO, these custom terms are retired and the DO terms substituted in existing annotations and subsequently used for curation.
G
ADAM17
ADAM metallopeptidase domain 17
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:24548422
NCBI chr17:6,589,874...6,638,788
Ensembl chr17:6,589,878...6,638,731
G
ADIPOQ
adiponectin, C1Q and collagen domain containing
ISO
RGD
PMID:17604368 PMID:21479819
RGD:5686754 RGD:5686898
NCBI chr34:19,398,310...19,410,519
Ensembl chr34:19,354,825...19,409,844
G
ADK
adenosine kinase
ISO
RGD
PMID:11123368
RGD:6482664
NCBI chr 4:24,540,626...25,047,032
Ensembl chr 4:24,540,659...25,046,464
G
ADRB3
adrenoceptor beta 3
ISO
mRNA:decreased expression:distal colon, mucosa (rat)
RGD
PMID:18492028
RGD:5684890
NCBI chr16:27,445,601...27,446,796
Ensembl chr16:27,445,601...27,447,521
G
AHR
aryl hydrocarbon receptor
ISO
CTD Direct Evidence: therapeutic
CTD
PMID:27783946
NCBI chr14:31,743,704...31,793,484
Ensembl chr14:31,686,170...31,791,444
G
ALOX5
arachidonate 5-lipoxygenase
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:15821759
NCBI chr28:2,170,920...2,218,765
Ensembl chr28:2,170,920...2,219,609
G
ANXA1
annexin A1
ISO
protein:increased expression:colon, neutrophil
RGD
PMID:10489933
RGD:2306920
NCBI chr 1:84,744,159...84,763,011
Ensembl chr 1:84,744,163...84,763,011
G
APLN
apelin
ISO
RGD
PMID:17391779
RGD:1626177
NCBI chr X:100,863,360...100,873,105
G
APOA4
apolipoprotein A4
ISO
human protein in mouse model
RGD
PMID:15254593
RGD:5685667
NCBI chr 5:16,751,588...16,754,215
Ensembl chr 5:16,751,799...16,754,837
G
AQP7
aquaporin 7
ISO
associated with Infection;mRNA, protein:decreased expression:colon
RGD
PMID:15338270
RGD:1626292
NCBI chr11:50,474,007...50,488,191
G
ARG1
arginase 1
severity
ISO
RGD
PMID:28423665
RGD:39939041
NCBI chr12:242,717...255,736
Ensembl chr12:242,714...255,305
G
ARRB1
arrestin beta 1
ISO
protein:increased expression:colon (rat)
RGD
PMID:21066892
RGD:5509893
NCBI chr21:23,261,020...23,304,448
Ensembl chr21:23,235,711...23,297,786
G
ATP5F1D
ATP synthase F1 subunit delta
treatment
ISO
RGD
PMID:23840258
RGD:13792680
NCBI chr20:57,547,575...57,550,110
Ensembl chr20:57,547,371...57,549,722
G
BDNF
brain derived neurotrophic factor
ISO
protein:increased expression:dorsal root ganglion:
RGD
PMID:19932037
RGD:8657331
NCBI chr21:48,191,580...48,243,699
Ensembl chr21:48,192,670...48,204,480
G
BMP6
bone morphogenetic protein 6
ISO
RGD
PMID:22361727
RGD:7242194
NCBI chr35:7,780,763...7,833,095
Ensembl chr35:7,804,231...7,831,845
G
BTK
Bruton tyrosine kinase
ameliorates
ISO
Associated with candidiasis
RGD
PMID:25379804
RGD:124713568
NCBI chr X:75,270,952...75,302,663
Ensembl chr X:75,270,979...75,302,562
G
CAT
catalase
ISO
RGD
PMID:21463646
RGD:5130869
NCBI chr18:33,383,005...33,422,447
Ensembl chr18:33,383,005...33,422,447
G
CCKBR
cholecystokinin B receptor
ISO
RGD
PMID:15102523
RGD:2311333
NCBI chr21:29,602,066...29,606,343
Ensembl chr21:29,604,150...29,605,725
G
CCL2
C-C motif chemokine ligand 2
ISO
RGD
PMID:18690297
RGD:2307009
NCBI chr 9:39,008,187...39,009,932
G
CCR1
chemokine (C-C motif) receptor 1
ISO
RGD
PMID:16399111
RGD:2307162
NCBI chr20:42,421,356...42,427,177
Ensembl chr20:42,421,356...42,426,958
G
CD36
CD36 molecule (CD36 blood group)
ISO
RGD
PMID:19117124
RGD:6893503
NCBI chr18:20,299,808...20,375,856
Ensembl chr18:20,339,050...20,372,639
G
CD40
CD40 molecule
ISO
RGD
PMID:15591506
RGD:5508169
NCBI chr24:33,352,992...33,383,488
Ensembl chr24:33,372,930...33,383,301
G
CHEK2
checkpoint kinase 2
ISO
ClinVar Annotator: match by term: Colitis
ClinVar
PMID:10617473 PMID:11053450 PMID:11479205 PMID:11719428 PMID:11967536 PMID:12094328 PMID:12533788 PMID:12690581 PMID:14648717 PMID:14648718 PMID:14648719 PMID:15087378 PMID:15095295 PMID:15122511 PMID:15466005 PMID:15488637 PMID:15492928 PMID:15520402 PMID:16257342 PMID:16492927 PMID:16880452 PMID:17085682 PMID:18172190 PMID:18759107 PMID:19338683 PMID:19768534 PMID:19805189 PMID:21779515 PMID:21807500 PMID:21876083 PMID:21956126 PMID:22006311 PMID:22058428 PMID:22419737 PMID:22811390 PMID:22994785 PMID:23109706 PMID:23329222 PMID:23415889 PMID:23469205 PMID:23652375 PMID:23946381 PMID:24033266 PMID:24713400 PMID:24723567 PMID:24884479 PMID:25431674 PMID:25583358 PMID:25741868 PMID:26084796 PMID:26332814 PMID:26467025 PMID:26641009 PMID:26681312 PMID:26822237 PMID:26845104 PMID:26884562 PMID:26976419 PMID:27083775 PMID:27153395 PMID:27223485 PMID:27269948 PMID:27433846 PMID:27711073 PMID:27751358 PMID:27798748 PMID:28125075 PMID:28135145 PMID:28195393 PMID:28492532 PMID:28503720 PMID:28514723 PMID:28727877 PMID:28734145 PMID:28779002 PMID:28802053 PMID:28874143 PMID:29146883 PMID:29351919 PMID:29489754 PMID:29522266 PMID:29909568 PMID:31300551 PMID:31993860 PMID:32119081 PMID:32285038 PMID:32295079 PMID:32383162 PMID:32531112 PMID:32805687 PMID:36222830 PMID:37055167 PMID:37149759 More...
NCBI chr26:22,052,256...22,145,675
Ensembl chr26:21,427,961...22,240,624
G
CHUK
component of inhibitor of nuclear factor kappa B kinase complex
treatment
ISO
RGD
PMID:17543437
RGD:2298659
NCBI chr28:12,964,670...13,001,557
Ensembl chr28:12,965,479...13,001,512
G
CIITA
class II major histocompatibility complex transactivator
severity
ISO
protein:increased expression:T cells:constitutive expression of transgene increases severity ClinVar Annotator: match by term: Colitis
RGD ClinVar
PMID:17043423 PMID:25741868 PMID:28492532
RGD:5491188
NCBI chr 6:31,774,486...31,837,025
Ensembl chr 6:31,774,609...31,836,820
G
CRHR2
corticotropin releasing hormone receptor 2
ISO
mRNA, protein:decreased expression:intestine, myenteric nerve plexus
RGD
PMID:17586086 PMID:21330446
RGD:5131259 RGD:5490987
NCBI chr14:43,366,849...43,414,398
Ensembl chr14:43,368,340...43,415,142
G
CTSB
cathepsin B
ISO
protein:increased activity:cecum, colon, spinal cord
RGD
PMID:21802389
RGD:5686873
NCBI chr25:26,048,237...26,056,570
Ensembl chr25:26,048,253...26,055,801
G
CTSL3
cathepsin L family member 3
ISO
protein:increased activity:cecum, colon, spinal cord
RGD
PMID:21802389
RGD:5686873
NCBI chr 1:72,215,774...72,219,093
G
CTSS
cathepsin S
ISO
protein:increased activity:cecum, colon, spinal cord
RGD
PMID:21802389
RGD:5686873
NCBI chr17:59,893,840...59,910,878
Ensembl chr17:59,893,840...59,910,849
G
CXCL8
C-X-C motif chemokine ligand 8
ISO
associated with Helicobacter Infections;mRNA:decreased expression:colon (mouse, Helicobacter hepaticus)
RGD
PMID:17242461
RGD:38549339
NCBI chr13:62,435,035...62,438,354
Ensembl chr13:62,434,422...62,438,354
G
CXCR2
C-X-C motif chemokine receptor 2
ISO
RGD
PMID:14738862
RGD:7257706
NCBI chr37:24,831,351...24,846,387
Ensembl chr37:24,843,171...24,844,247
G
CYP1A1
cytochrome P450 family 1 subfamily A member 1
ISO
mRNA:increased expression:large intestine epithelium
RGD
PMID:21374063
RGD:5147670
NCBI chr30:37,793,277...37,799,535
Ensembl chr30:37,793,508...37,796,866
G
DLA88
MHC class I DLA-88
ISO
human gene in rat model; DNA:polymorphism:cds:HLA-B27 (human)
RGD
PMID:2257626
RGD:7387221
NCBI chr12:892,442...895,691
Ensembl chr12:892,388...1,021,690
G
DUSP1
dual specificity phosphatase 1
severity
ISO
RGD
PMID:22461024
RGD:7771532
NCBI chr 4:39,588,833...39,591,065
Ensembl chr 4:39,588,339...39,590,514
G
ESR2
estrogen receptor 2
ISO
mRNA:decreased expression:colon
RGD
PMID:21252046
RGD:5508810
NCBI chr 8:38,645,917...38,715,347
Ensembl chr 8:38,645,430...38,702,691
G
FGF19
fibroblast growth factor 19
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:27580383
NCBI chr18:48,464,931...48,469,967
Ensembl chr18:48,464,928...48,469,782
G
FLNA
filamin A
ISO
ClinVar Annotator: match by term: Colitis
ClinVar
PMID:25741868 PMID:28492532 PMID:30755392
NCBI chr X:122,058,303...122,083,467
Ensembl chr X:122,061,455...122,083,203
G
GCG
glucagon
ISO
CTD Direct Evidence: therapeutic
CTD
PMID:22323126
NCBI chr36:7,544,637...7,554,171
Ensembl chr36:7,544,637...7,554,021
G
GHRL
ghrelin and obestatin prepropeptide
ISO
CTD Direct Evidence: therapeutic
CTD
PMID:19617644
NCBI chr20:8,092,921...8,097,512
Ensembl chr20:8,092,957...8,097,510
G
HAVCR1
hepatitis A virus cellular receptor 1
ISO
mRNA:increased expression:kidney:
RGD
PMID:23307618
RGD:7245473
NCBI chr 4:53,012,223...53,066,611
Ensembl chr 4:53,046,970...53,128,952 Ensembl chr 4:53,046,970...53,128,952
G
HMOX1
heme oxygenase 1
treatment
ISO
protein:increased expression:colon: CTD Direct Evidence: therapeutic
RGD CTD
PMID:16365149 PMID:21444764 PMID:21853095 PMID:22261574
RGD:10766442 RGD:7207796
NCBI chr10:28,744,404...28,751,544
Ensembl chr10:28,743,795...28,751,773
G
ICAM1
intercellular adhesion molecule 1
ISO
protein:increased expression:colon:
RGD
PMID:22261574
RGD:7207796
NCBI chr20:50,818,715...50,827,914
Ensembl chr20:50,818,715...50,827,914
G
ICOS
inducible T cell costimulator
ISO
protein:increased expression:T-cell
RGD
PMID:14731127
RGD:1624274
NCBI chr37:12,663,839...12,735,266
Ensembl chr37:12,670,999...12,733,458
G
IFNG
interferon gamma
ISO
CTD Direct Evidence: marker/mechanism
CTD RGD
PMID:16717119 PMID:24548422
RGD:150573704
NCBI chr10:10,406,866...10,411,698
Ensembl chr10:10,406,867...10,411,698
G
IGF1
insulin like growth factor 1
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:24782617
NCBI chr15:41,203,320...41,275,964
Ensembl chr15:41,202,518...41,275,794
G
IKBKB
inhibitor of nuclear factor kappa B kinase subunit beta
treatment
ISO
RGD
PMID:17543437
RGD:2298659
NCBI chr16:23,359,551...23,419,114
Ensembl chr16:23,359,813...23,419,075
G
IL10
interleukin 10
treatment
ISO
CTD Direct Evidence: marker/mechanism|therapeutic
CTD RGD
PMID:19238344 PMID:21807089 PMID:21949848 PMID:22119709 PMID:22461024 PMID:23771723 PMID:24314293 More...
RGD:7349385 RGD:7365024 RGD:7771532
NCBI chr 7:5,933,285...5,937,057
Ensembl chr 7:5,933,285...5,937,057
G
IL17A
interleukin 17A
ISO
CTD Direct Evidence: marker/mechanism mRNA:increased expression:colon
RGD CTD
PMID:14962796 PMID:20881082 PMID:24548422
RGD:4781448 RGD:4888509
NCBI chr12:19,854,129...19,862,521
Ensembl chr12:19,854,129...19,862,513
G
IL1B
interleukin 1 beta
ISO
CTD Direct Evidence: marker/mechanism
RGD CTD
PMID:22969190 PMID:23810507 PMID:24548422
RGD:7204699
NCBI chr17:37,019,329...37,033,388
Ensembl chr17:37,019,329...37,024,458
G
IL1RL1
interleukin 1 receptor like 1
severity
ISO
RGD
PMID:23172891
RGD:40400694
NCBI chr10:40,658,191...40,732,097
Ensembl chr10:40,659,041...40,677,357
G
IL33
interleukin 33
severity
ISO
RGD
PMID:23172891 PMID:28423665
RGD:39939041 RGD:40400694
NCBI chr11:27,219,878...27,256,723
Ensembl chr11:27,219,878...27,256,721
G
IL4
interleukin 4
treatment
ISO
CTD Direct Evidence: therapeutic
CTD RGD
PMID:9389741 PMID:24314293
RGD:8142400
NCBI chr11:20,972,693...20,981,539
Ensembl chr11:20,972,690...20,981,534
G
IL5
interleukin 5
ISO
protein: increased expression
RGD
PMID:22018693
RGD:5687148
NCBI chr11:20,825,469...20,827,269
Ensembl chr11:20,825,469...20,827,269
G
IL6
interleukin 6
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:22410118 PMID:24548422
NCBI chr14:36,474,268...36,478,519
Ensembl chr14:36,473,394...36,478,519
G
ITGB2
integrin subunit beta 2
ISO
associated with Spirochaetales infections
RGD
PMID:11031123
RGD:6482227
NCBI chr31:38,520,733...38,547,003
Ensembl chr31:38,521,103...38,547,018
G
KDR
kinase insert domain receptor
ISO
protein:increased expression:colon:
RGD
PMID:22261574
RGD:7207796
NCBI chr13:47,442,861...47,484,574
Ensembl chr13:47,442,764...47,485,042
G
LCT
lactase
ISO
protein:decreased expression, increased expression:jejunum
RGD
PMID:17218984
RGD:1600240
NCBI chr19:38,571,539...38,620,567
Ensembl chr19:38,572,058...38,620,567
G
LRRK2
leucine rich repeat kinase 2
ISO
RGD
PMID:21983832
RGD:5508401
NCBI chr27:13,282,824...13,420,917
Ensembl chr27:13,283,756...13,420,870
G
MADCAM1
mucosal vascular addressin cell adhesion molecule 1
ISO
CTD Direct Evidence: therapeutic
CTD
PMID:16917232
NCBI chr20:57,978,189...57,981,966
Ensembl chr20:57,978,185...57,981,966
G
MC1R
melanocortin 1 receptor
ISO
RGD
PMID:16543288
RGD:5687320
NCBI chr 5:63,694,296...63,695,249
G
MIF
macrophage migration inhibitory factor
ISO
CTD Direct Evidence: therapeutic
CTD RGD
PMID:12105854 PMID:17324399
RGD:1641979
G
MIR150
microRNA mir-150
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:26937033
NCBI chr 1:106,998,756...106,998,812
Ensembl chr 1:106,998,756...106,998,812
G
MPO
myeloperoxidase
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:23810507
NCBI chr 9:32,927,483...32,938,007
Ensembl chr 9:32,927,483...32,937,820
G
MSH2
mutS homolog 2
ISO
RGD
PMID:23883737
RGD:10412318
NCBI chr10:49,517,448...49,594,001
Ensembl chr10:49,517,369...49,594,210
G
MUC17
mucin 17, cell surface associated
treatment
ISO
mRNA:increased expression:ileum, colon
RGD
PMID:16964428 PMID:23395625
RGD:1625545 RGD:7349360
G
MUC2
mucin 2, oligomeric mucus/gel-forming
treatment
ISO
mRNA:decreased expression:colon protein:decreased sulfation:descending colon
RGD
PMID:12395902 PMID:19220658 PMID:21949848 PMID:23395625
RGD:2324675 RGD:7349356 RGD:7349360 RGD:7349385
NCBI chr18:45,416,347...45,438,226
G
NAMPT
nicotinamide phosphoribosyltransferase
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:23810507
NCBI chr18:14,110,045...14,211,268
Ensembl chr18:13,993,022...14,208,657
G
NFE2L2
NFE2 like bZIP transcription factor 2
treatment
ISO
RGD
PMID:30142311
RGD:42724458
NCBI chr36:20,989,205...21,087,044
Ensembl chr36:20,989,360...21,012,524
G
NOD1
nucleotide binding oligomerization domain containing 1
ISO
RGD
PMID:20921147
RGD:5508755
NCBI chr14:43,162,671...43,226,948
Ensembl chr14:43,163,571...43,227,103
G
NOD2
nucleotide binding oligomerization domain containing 2
ISO
mRNA:increased expression:colon
RGD
PMID:16891783 PMID:20921147 PMID:21471573
RGD:1600781 RGD:5508727 RGD:5508755
NCBI chr 2:64,636,850...64,667,232
Ensembl chr 2:64,635,519...64,667,232
G
NOS2
nitric oxide synthase 2
ISO
mRNA:increased expression:colon mRNA:increased expression:colon (mouse) CTD Direct Evidence: marker/mechanism
RGD CTD
PMID:8698225 PMID:16866779 PMID:17449036 PMID:21930116
RGD:4891411 RGD:5509045
NCBI chr 9:42,171,821...42,210,217
Ensembl chr 9:42,171,821...42,208,588
G
NOS3
nitric oxide synthase 3
ISO
mRNA:increased expression:colon
RGD
PMID:17947450
RGD:2292124
NCBI chr16:15,054,196...15,072,454
Ensembl chr16:15,011,344...15,072,277
G
NTRK1
neurotrophic receptor tyrosine kinase 1
ISO
mRNA, protein:increased expression:neuron
RGD
PMID:20638179
RGD:5684542
NCBI chr 7:41,140,931...41,159,326
Ensembl chr 7:41,140,879...41,159,288
G
NTRK2
neurotrophic receptor tyrosine kinase 2
ISO
mRNA, protein:increased expression:dorsal root ganglion
RGD
PMID:20638179
RGD:5684542
NCBI chr 1:74,447,927...74,777,910
Ensembl chr 1:74,449,060...74,777,032
G
PGF
placental growth factor
ISO
RGD
PMID:20142801
RGD:6483587
NCBI chr 8:48,059,554...48,110,534
Ensembl chr 8:48,059,552...48,075,170
G
PIK3CG
phosphatidylinositol-4,5-bisphosphate 3-kinase catalytic subunit gamma
ISO
RGD
PMID:21244371
RGD:6482682
NCBI chr18:13,576,966...13,611,748
Ensembl chr18:13,570,999...13,611,141
G
PPARA
peroxisome proliferator activated receptor alpha
susceptibility
ISO
RGD
PMID:20650341
RGD:5509936
NCBI chr10:19,934,020...20,006,096
Ensembl chr10:19,934,165...20,006,146
G
PPARGC1A
PPARG coactivator 1 alpha
ISO
RGD
PMID:22126533
RGD:6484264
NCBI chr 3:85,645,942...86,284,570
Ensembl chr 3:86,016,140...86,281,269
G
PTGER4
prostaglandin E receptor 4
ISO
RGD
PMID:20833794
RGD:6483551
NCBI chr 4:68,663,362...68,676,241
Ensembl chr 4:68,663,364...68,676,358
G
PTGS2
prostaglandin-endoperoxide synthase 2
treatment
ISO
CTD Direct Evidence: marker/mechanism
CTD RGD
PMID:11820457 PMID:17543437
RGD:2298659
NCBI chr 7:19,668,079...19,674,903
Ensembl chr 7:19,668,082...19,674,903
G
RELA
RELA proto-oncogene, NF-kB subunit
ISO
CTD Direct Evidence: marker/mechanism protein:increased expression:nucleus
CTD RGD
PMID:18623154 PMID:23810507
RGD:2298776
NCBI chr18:51,550,003...51,558,861
Ensembl chr18:51,550,040...51,558,875
G
REN
renin
treatment
ISO
RGD
PMID:24858618
RGD:125097500
NCBI chr38:744,540...766,998
Ensembl chr38:744,614...755,012
G
RETN
resistin
treatment
ISO
RGD
PMID:22630819
RGD:7207222
NCBI chr20:52,434,148...52,435,627
Ensembl chr20:52,434,271...52,435,624
G
SELL
selectin L
ISO
RGD
PMID:18054560
RGD:5685703
NCBI chr 7:28,906,752...28,927,959
Ensembl chr 7:28,906,809...29,094,008
G
SELP
selectin P
ISO
protein:increased expression:colon
RGD
PMID:19147805
RGD:2312310
NCBI chr 7:28,956,428...28,997,266
Ensembl chr 7:28,958,486...28,996,313
G
SELPLG
selectin P ligand
ISO
RGD
PMID:22009715
RGD:6218987
NCBI chr26:18,250,260...18,259,996
Ensembl chr26:18,250,295...18,259,765
G
SI
sucrase-isomaltase
ISO
mRNA, protein:decreased expression:ileum
RGD
PMID:16964428
RGD:1625545
NCBI chr34:30,284,869...30,373,749
Ensembl chr34:30,284,858...30,373,780
G
SIRT1
sirtuin 1
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:19940103 PMID:24548422 PMID:24782617
NCBI chr 4:19,188,616...19,220,031
Ensembl chr 4:19,188,675...19,218,279
G
SLC11A1
solute carrier family 11 member 1
ISO
RGD
PMID:19016783
RGD:5684975
NCBI chr37:25,039,203...25,047,461
Ensembl chr37:25,038,360...25,047,282
G
SOCS1
suppressor of cytokine signaling 1
ISO
RGD
PMID:16717119
RGD:150573704
NCBI chr 6:31,511,003...31,511,995
Ensembl chr 6:31,509,268...31,511,557
G
SRC
SRC proto-oncogene, non-receptor tyrosine kinase
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:17551092
NCBI chr24:25,982,499...26,019,748
Ensembl chr24:25,999,048...26,018,077
G
SYK
spleen associated tyrosine kinase
ISO
ClinVar Annotator: match by term: Colitis
ClinVar
PMID:25741868 PMID:28492532 PMID:33782605
NCBI chr 1:95,903,501...95,955,577
Ensembl chr 1:95,903,566...95,955,583
G
TAC1
tachykinin precursor 1
ISO
RGD
PMID:18715640
RGD:2304260
NCBI chr14:22,631,106...22,640,283
Ensembl chr14:22,632,642...22,640,258
G
TACR1
tachykinin receptor 1
ISO
RGD
PMID:18715640
RGD:2304260
NCBI chr17:48,038,010...48,178,971
Ensembl chr17:48,038,010...48,178,971
G
TACR2
tachykinin receptor 2
ISO
RGD
PMID:12490601 PMID:18715640
RGD:2304260 RGD:5147478
NCBI chr 4:20,518,797...20,531,118
Ensembl chr 4:20,517,563...20,531,867
G
TFF1
trefoil factor 1
ISO
RGD
PMID:8836141
RGD:625375
NCBI chr31:36,681,478...36,684,571
Ensembl chr31:36,681,357...36,695,665
G
TIMP3
TIMP metallopeptidase inhibitor 3
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:24548422
NCBI chr10:30,627,154...30,681,520
Ensembl chr10:30,627,154...30,694,288
G
TLR3
toll like receptor 3
ISO
mRNA:increased expression:large intestine mucosa (rat)
RGD
PMID:20011045
RGD:5128708
NCBI chr16:44,617,012...44,633,591
Ensembl chr16:44,550,846...44,653,247
G
TLR4
toll like receptor 4
ISO
protein:increased expression:colon
RGD
PMID:19002562 PMID:19924809
RGD:2312573 RGD:7794773
NCBI chr11:71,356,390...71,367,166
Ensembl chr11:71,356,390...71,367,165
G
TNF
tumor necrosis factor
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:23810507 PMID:24548422
NCBI chr12:1,074,561...1,076,425
Ensembl chr12:1,074,552...1,076,425
G
TREM1
triggering receptor expressed on myeloid cells 1
severity
ISO
RGD
PMID:24453980
RGD:126925972
NCBI chr12:9,990,678...10,000,195
Ensembl chr12:9,990,679...10,000,236
G
TST
thiosulfate sulfurtransferase
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:19647029
NCBI chr10:27,474,101...27,486,603
Ensembl chr10:27,473,764...27,486,575
G
UCN
urocortin
ISO
mRNA:altered expression:distal colon (rat)
RGD
PMID:21330446
RGD:5490987
NCBI chr17:21,278,512...21,280,404
Ensembl chr17:21,278,932...21,279,312
G
UCN2
urocortin 2
ISO
mRNA:increased expression:colon (rat)
RGD
PMID:17586086
RGD:5131259
NCBI chr20:40,551,060...40,552,920
G
VCAM1
vascular cell adhesion molecule 1
ISO
protein:increased expression:colon:
RGD
PMID:22261574
RGD:7207796
NCBI chr 6:49,341,669...49,359,841
Ensembl chr 6:49,342,151...49,359,933
G
VIP
vasoactive intestinal peptide
ISO
associated with Gram-Negative Bacterial Infections
RGD
PMID:19661153
RGD:5685605
NCBI chr 1:42,941,655...42,950,160
Ensembl chr 1:42,941,224...42,950,700
G
VIPR2
vasoactive intestinal peptide receptor 2
ISO
RGD
PMID:21295288
RGD:5685384
NCBI chr16:20,925,032...20,987,513
Ensembl chr16:20,927,991...20,987,785
G
ACE
angiotensin I converting enzyme
ISO
protein:increased expression:small intestine, large intestine:extracellular space (mouse)
RGD
PMID:26401072
RGD:11555935
NCBI chr 9:11,497,182...11,516,362
Ensembl chr 9:11,497,182...11,516,358
G
ACE2
angiotensin converting enzyme 2
severity
ISO
Ace2 knockout Ace2 inhibitor
RGD
PMID:19517214 PMID:22837003
RGD:40818307 RGD:40818410
NCBI chr X:11,798,839...11,839,591
Ensembl chr X:11,798,839...11,900,594
G
CASP3
caspase 3
treatment
ISO
RGD
PMID:28740344
RGD:13782278
NCBI chr16:45,920,074...45,940,507
Ensembl chr16:45,920,071...45,940,505
G
CASP7
caspase 7
treatment
ISO
RGD
PMID:28740344
RGD:13782278
NCBI chr28:24,599,866...24,630,018
Ensembl chr28:24,599,493...24,628,668
G
SERPINA1
serpin family A member 1
treatment
ISO
RGD
PMID:23835442
RGD:14695050
NCBI chr 8:63,388,498...63,400,377
Ensembl chr 8:63,376,945...63,398,435
G
IL23A
interleukin 23 subunit alpha
severity
ISO
RGD
PMID:26455347
RGD:11097134
NCBI chr10:635,384...640,715
Ensembl chr10:638,719...640,359
G
IL33
interleukin 33
severity treatment
ISO
RGD
PMID:32156806
RGD:40400894
NCBI chr11:27,219,878...27,256,723
Ensembl chr11:27,219,878...27,256,721
G
ACE
angiotensin I converting enzyme
treatment
ISO
RGD
PMID:17342403 PMID:24239644
RGD:40400720 RGD:40400748
NCBI chr 9:11,497,182...11,516,362
Ensembl chr 9:11,497,182...11,516,358
G
ACER3
alkaline ceramidase 3
severity
ISO
mRNA,protein:decreased expression, decreased activity:colon:
RGD
PMID:26938296
RGD:35673322
NCBI chr21:21,711,315...21,863,409
Ensembl chr21:21,714,156...21,863,320
G
ADAM17
ADAM metallopeptidase domain 17
treatment
ISO
RGD
PMID:11884025
RGD:632022
NCBI chr17:6,589,874...6,638,788
Ensembl chr17:6,589,878...6,638,731
G
ADRB3
adrenoceptor beta 3
no_association
ISO
mRNA:unaltered expression:colon (rat)
RGD
PMID:11803250
RGD:5684894
NCBI chr16:27,445,601...27,446,796
Ensembl chr16:27,445,601...27,447,521
G
AGER
advanced glycosylation end-product specific receptor
treatment
ISO
RGD
PMID:29572553
RGD:152995414
NCBI chr12:1,574,251...1,577,410
Ensembl chr12:1,574,251...1,577,129
G
AKT1
AKT serine/threonine kinase 1
treatment
ISO
RGD
PMID:29572553
RGD:152995414
NCBI chr 8:72,317,399...72,335,686
Ensembl chr 8:72,317,869...72,335,193
G
ATM
ATM serine/threonine kinase
exacerbates
ISO
RGD
PMID:20179206
RGD:126781749
NCBI chr 5:24,180,129...24,297,207
Ensembl chr 5:24,182,135...24,297,207
G
ATP5F1A
ATP synthase F1 subunit alpha
treatment
ISO
RGD
PMID:25689466
RGD:13703055
NCBI chr 7:45,118,188...45,127,048
Ensembl chr 7:45,117,657...45,127,048
G
BCL2
BCL2 apoptosis regulator
treatment
ISO
RGD
PMID:29572553
RGD:152995414
NCBI chr 1:13,733,849...13,900,653
Ensembl chr 1:13,731,406...13,900,658
G
BIRC3
baculoviral IAP repeat containing 3
exacerbates
ISO
RGD
PMID:26037070
RGD:11537970
NCBI chr 5:29,324,893...29,343,322
Ensembl chr 5:29,325,331...29,337,240
G
CD68
CD68 molecule
treatment
ISO
RGD
PMID:25004394
RGD:40925931
NCBI chr 5:32,500,899...32,503,355
Ensembl chr 5:32,501,380...32,503,183
G
CHRNA7
cholinergic receptor nicotinic alpha 7 subunit
treatment
ISO
RGD
PMID:29572553
RGD:152995414
NCBI chr 3:36,852,082...37,164,930
Ensembl chr 3:36,852,543...36,978,399
G
CSF1R
colony stimulating factor 1 receptor
ameliorates
ISO
RGD
PMID:23451116
RGD:150524300
NCBI chr 4:58,980,699...59,010,683
Ensembl chr 4:58,980,788...59,010,510
G
CSF3
colony stimulating factor 3
treatment
ISO
RGD
PMID:16689657
RGD:11039462
NCBI chr 9:22,529,643...22,532,326
Ensembl chr 9:22,530,698...22,533,108
G
CXCL8
C-X-C motif chemokine ligand 8
treatment
ISO
RGD
PMID:29655167
RGD:39939058
NCBI chr13:62,435,035...62,438,354
Ensembl chr13:62,434,422...62,438,354
G
EREG
epiregulin
ISO
protein:increased expression:colonic mucosa (mouse)
RGD
PMID:20498653
RGD:39457688
NCBI chr13:62,857,325...62,877,831
Ensembl chr13:62,856,709...62,877,760
G
EZH2
enhancer of zeste 2 polycomb repressive complex 2 subunit
treatment
ISO
RGD
PMID:31160593
RGD:126779602
NCBI chr16:1,926,443...1,991,995
Ensembl chr16:1,925,956...1,991,838
G
FAS
Fas cell surface death receptor
treatment
ISO
RGD
PMID:22368862
RGD:10054108
NCBI chr26:38,738,811...38,763,298
Ensembl chr26:38,737,611...38,763,321
G
FGF10
fibroblast growth factor 10
treatment
ISO
human protein in mouse model with bacterial delivery system human gene product in mouse model
RGD
PMID:10381813 PMID:11952999 PMID:19736360 PMID:23676805
RGD:126928132 RGD:126928133 RGD:127284855 RGD:127284874
NCBI chr 4:65,851,130...65,930,944
Ensembl chr 4:65,851,069...65,928,192
G
FGF7
fibroblast growth factor 7
treatment
ISO
human protein in mouse model
RGD
PMID:10219846
RGD:126928136
NCBI chr30:15,555,016...15,608,230
Ensembl chr30:15,555,266...15,606,521
G
FOXP3
forkhead box P3
treatment
ISO
mRNA:increased expression:mucosa: protein:increased expression:colon:
RGD
PMID:17229795 PMID:26925602 PMID:27498708 PMID:28733028
RGD:14975101 RGD:38455994 RGD:38455995 RGD:38549362
NCBI chr X:42,331,229...42,362,841
Ensembl chr X:42,344,108...42,350,758
G
HAMP
hepcidin antimicrobial peptide
ISO
protein:increased expression:colon
RGD
PMID:24764672
RGD:11041628
NCBI chr 1:117,305,531...117,306,587
Ensembl chr 1:117,305,411...117,306,619
G
HMGB1
high mobility group box 1
treatment
ISO
RGD
PMID:29572553
RGD:152995414
NCBI chr25:9,431,223...9,558,167
Ensembl chr25:9,431,218...9,558,165
G
HSF1
heat shock transcription factor 1
ISO
protein:increased acetylation:colon (rat)
RGD
PMID:25608526
RGD:10402402
NCBI chr13:37,724,741...37,745,259
Ensembl chr13:37,724,759...37,745,252
G
ICAM1
intercellular adhesion molecule 1
treatment
ISO
RGD
PMID:10092309 PMID:29572553
RGD:11522714 RGD:152995414
NCBI chr20:50,818,715...50,827,914
Ensembl chr20:50,818,715...50,827,914
G
IFNG
interferon gamma
ISO
protein:increased expression:plasma:
RGD
PMID:15030379 PMID:27498708
RGD:10755756 RGD:14975101
NCBI chr10:10,406,866...10,411,698
Ensembl chr10:10,406,867...10,411,698
G
IFNGR1
interferon gamma receptor 1
ameliorates
ISO
RGD
PMID:25918247
RGD:124715468
NCBI chr 1:29,646,776...29,669,669
Ensembl chr 1:29,647,552...29,669,578
G
IL10
interleukin 10
treatment
ISO
associated with Helicobacter Infections
RGD
PMID:16982822 PMID:25727887 PMID:27815529 PMID:29572553
RGD:11049170 RGD:11049485 RGD:14975260 RGD:152995414
NCBI chr 7:5,933,285...5,937,057
Ensembl chr 7:5,933,285...5,937,057
G
IL1B
interleukin 1 beta
treatment
ISO
RGD
PMID:31175857
RGD:14975282
NCBI chr17:37,019,329...37,033,388
Ensembl chr17:37,019,329...37,024,458
G
IL1RN
interleukin 1 receptor antagonist
treatment
ISO
human protein in a rat model
RGD
PMID:8978354
RGD:8551835
NCBI chr17:37,236,690...37,250,424
Ensembl chr17:37,212,751...37,249,329
G
IL2
interleukin 2
ISO
RGD
PMID:16630696
RGD:8662978
NCBI chr19:17,750,780...17,756,394
Ensembl chr19:17,750,780...17,756,394
G
IL23A
interleukin 23 subunit alpha
severity
ISO
mRNA:increased expression:colon (mouse)
RGD
PMID:24028683
RGD:39458035
NCBI chr10:635,384...640,715
Ensembl chr10:638,719...640,359
G
IL25
interleukin 25
treatment
ISO
RGD
PMID:19118508
RGD:39456129
NCBI chr 8:3,621,268...3,624,689
Ensembl chr 8:3,618,161...3,624,043
G
IL33
interleukin 33
severity treatment
ISO
RGD
PMID:25112700 PMID:28423665
RGD:39938951 RGD:39939041
NCBI chr11:27,219,878...27,256,723
Ensembl chr11:27,219,878...27,256,721
G
IL6
interleukin 6
treatment
ISO
RGD
PMID:16133010 PMID:16630696 PMID:27096537
RGD:11062139 RGD:11062146 RGD:8662978
NCBI chr14:36,474,268...36,478,519
Ensembl chr14:36,473,394...36,478,519
G
IRF9
interferon regulatory factor 9
ameliorates
ISO
RGD
PMID:25918247
RGD:124715468
NCBI chr 8:4,152,146...4,157,201
G
ITGA2
integrin subunit alpha 2
treatment
ISO
RGD
PMID:16534417
RGD:11530069
NCBI chr 4:62,170,137...62,268,962
Ensembl chr 4:62,170,452...62,268,983
G
ITGA4
integrin subunit alpha 4
ISO
protein:increased expression:colon (rat)
RGD
PMID:12183646
RGD:729408
NCBI chr36:24,670,464...24,686,719
Ensembl chr36:24,653,408...24,729,057
G
JAK2
Janus kinase 2
treatment
ISO
RGD
PMID:29572553
RGD:152995414
NCBI chr 1:93,321,055...93,438,898
Ensembl chr 1:93,142,635...93,435,997
G
KCNMA1
potassium calcium-activated channel subfamily M alpha 1
ISO
mRNA, protein:increased expression:colon
RGD
PMID:23986198
RGD:10412026
NCBI chr 4:26,844,250...27,338,271
Ensembl chr 4:26,844,250...27,555,776
G
KDR
kinase insert domain receptor
ISO
protein:increased expression:colon
RGD
PMID:19013462
RGD:5684406
NCBI chr13:47,442,861...47,484,574
Ensembl chr13:47,442,764...47,485,042
G
KL
klotho
ISO
mRNA:decreased expression:kidney:
RGD
PMID:20004202
RGD:10403055
NCBI chr25:7,154,359...7,201,744
Ensembl chr25:7,156,620...7,199,558
G
MAPK1
mitogen-activated protein kinase 1
treatment
ISO
RGD
PMID:27028006
RGD:13800882
NCBI chr26:31,013,607...31,132,998
Ensembl chr26:31,013,607...31,132,998
G
MAPK3
mitogen-activated protein kinase 3
treatment
ISO
RGD
PMID:29037916
RGD:13800567
NCBI chr 6:18,109,184...18,115,728
Ensembl chr 6:18,109,222...18,114,425
G
MIF
macrophage migration inhibitory factor
severity
ISO
RGD
PMID:15807847
RGD:36947390
G
MIR155
microRNA mir-155
treatment
ISO
associated with Helicobacter Infections
RGD
PMID:21880981 PMID:28246471 PMID:28461115 PMID:28752563 PMID:30253332 PMID:30927737 More...
RGD:21079443 RGD:21079463 RGD:21079473 RGD:21081536 RGD:24922208 RGD:25314295
NCBI chr31:21,078,768...21,078,828
Ensembl chr31:21,078,758...21,078,833
G
MIR21
microRNA mir-21
ameliorates
ISO
RGD
PMID:23826144
RGD:41404691
NCBI chr 9:34,340,550...34,340,609
Ensembl chr 9:34,340,533...34,340,624
G
MMP2
matrix metallopeptidase 2
treatment
ISO
RGD
PMID:23323009
RGD:13207328
NCBI chr 2:60,471,092...60,492,991
Ensembl chr 2:60,471,257...60,494,113
G
MMP9
matrix metallopeptidase 9
treatment
ISO
RGD
PMID:23323009
RGD:13207328
NCBI chr24:33,274,260...33,281,116
Ensembl chr24:33,274,268...33,281,293
G
MPO
myeloperoxidase
treatment
ISO
RGD
PMID:29572553
RGD:152995414
NCBI chr 9:32,927,483...32,938,007
Ensembl chr 9:32,927,483...32,937,820
G
MYD88
MYD88 innate immune signal transduction adaptor
exacerbates
ISO
RGD
PMID:25362351
RGD:150521530
NCBI chr23:7,901,578...7,905,274
Ensembl chr23:7,901,250...7,904,534
G
NFE2L2
NFE2 like bZIP transcription factor 2
treatment
ISO
RGD
PMID:22350949
RGD:10412739
NCBI chr36:20,989,205...21,087,044
Ensembl chr36:20,989,360...21,012,524
G
NFKBIA
NFKB inhibitor alpha
treatment
ISO
RGD
PMID:21642017
RGD:10413866
NCBI chr 8:14,100,203...14,103,453
Ensembl chr 8:14,100,671...14,103,433
G
NOD2
nucleotide binding oligomerization domain containing 2
ISO
protein:increased expression:colonic mucosa:
RGD
PMID:22997830
RGD:13204727
NCBI chr 2:64,636,850...64,667,232
Ensembl chr 2:64,635,519...64,667,232
G
NPY
neuropeptide Y
treatment
ISO
RGD
PMID:20533056
RGD:10448943
NCBI chr14:37,824,579...37,831,289
Ensembl chr14:37,823,861...37,831,443
G
PDGFRA
platelet derived growth factor receptor alpha
treatment
ISO
RGD
PMID:24115822
RGD:11080973
NCBI chr13:46,729,722...46,775,828
Ensembl chr13:46,730,703...46,773,278
G
PDGFRB
platelet derived growth factor receptor beta
treatment
ISO
RGD
PMID:24115822
RGD:11080973
NCBI chr 4:58,925,922...58,963,639
Ensembl chr 4:58,926,351...58,962,283
G
PHEX
phosphate regulating endopeptidase X-linked
ISO
mRNA:decreased expression:bone:
RGD
PMID:16890604
RGD:11556253
NCBI chr X:17,830,714...18,038,755
Ensembl chr X:17,829,158...18,035,775
G
PIK3CG
phosphatidylinositol-4,5-bisphosphate 3-kinase catalytic subunit gamma
susceptibility
ISO
RGD
PMID:20347874
RGD:38599183
NCBI chr18:13,576,966...13,611,748
Ensembl chr18:13,570,999...13,611,141
G
PTGER4
prostaglandin E receptor 4
treatment
ISO
RGD
PMID:12100473
RGD:727388
NCBI chr 4:68,663,362...68,676,241
Ensembl chr 4:68,663,364...68,676,358
G
RELA
RELA proto-oncogene, NF-kB subunit
treatment
ISO
RGD
PMID:29572553
RGD:152995414
NCBI chr18:51,550,003...51,558,861
Ensembl chr18:51,550,040...51,558,875
G
RNASEL
ribonuclease L
severity
ISO
RGD
PMID:23567782
RGD:40902808
NCBI chr 7:15,978,055...16,001,604
Ensembl chr 7:15,856,151...16,001,569
G
SLC11A1
solute carrier family 11 member 1
ISO
RGD
PMID:19116231
RGD:5684934
NCBI chr37:25,039,203...25,047,461
Ensembl chr37:25,038,360...25,047,282
G
SMAD4
SMAD family member 4
susceptibility
ISO
RGD
PMID:23090737
RGD:12880038
NCBI chr 1:23,875,989...23,930,027
Ensembl chr 1:23,882,139...23,969,405
G
SOCS3
suppressor of cytokine signaling 3
treatment
ISO
RGD
PMID:29572553
RGD:152995414
NCBI chr 9:2,859,267...2,859,944
G
TNF
tumor necrosis factor
treatment
ISO
RGD
PMID:21296062 PMID:29572553
RGD:152995414 RGD:8661763
NCBI chr12:1,074,561...1,076,425
Ensembl chr12:1,074,552...1,076,425
G
TNFRSF1A
TNF receptor superfamily member 1A
treatment
ISO
RGD
PMID:21296062
RGD:8661763
NCBI chr27:38,641,837...38,654,693
Ensembl chr27:38,638,753...38,700,282
G
VEGFA
vascular endothelial growth factor A
ISO
protein:increased expression:colon
RGD
PMID:19013462
RGD:5684406
NCBI chr12:12,209,032...12,224,978
Ensembl chr12:12,208,231...12,224,965
G
SERPINE1
serpin family E member 1
susceptibility
ISO
DNA:polymorphism:promoter:rs1799768 (human)
RGD
PMID:25656775
RGD:13208543
NCBI chr 6:8,719,547...8,727,160
Ensembl chr 6:8,720,825...8,726,301
G
VEGFA
vascular endothelial growth factor A
ISO
RGD
PMID:15770733
RGD:1580570
NCBI chr12:12,209,032...12,224,978
Ensembl chr12:12,208,231...12,224,965
G
IL1RN
interleukin 1 receptor antagonist
ISO
protein:increased concentration:serum (human)
RGD
PMID:9802632
RGD:6909134
NCBI chr17:37,236,690...37,250,424
Ensembl chr17:37,212,751...37,249,329
G
ABCB1
ATP binding cassette subfamily B member 1
susceptibility
ISO
RGD
PMID:15505619
RGD:1598568
NCBI chr14:13,644,891...13,852,829
Ensembl chr14:13,542,647...13,742,727
G
ACSM3
acyl-CoA synthetase medium chain family member 3
ISO
mRNA:decreased expression:colonic mucosa
RGD
PMID:21987487
RGD:7241281
NCBI chr 6:24,558,010...24,594,326
Ensembl chr 6:24,558,142...24,582,728
G
ADCY7
adenylate cyclase 7
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:28067910
NCBI chr 2:65,003,891...65,034,812
Ensembl chr 2:65,006,038...65,034,777
G
ADIPOQ
adiponectin, C1Q and collagen domain containing
ISO
protein:increased expression:serum
RGD
PMID:16432373
RGD:5686726
NCBI chr34:19,398,310...19,410,519
Ensembl chr34:19,354,825...19,409,844
G
ADRB2
adrenoceptor beta 2
ISO
protein:decreased expression:large intestine mucosa,spleen
RGD
PMID:22772914
RGD:7175063
NCBI chr 4:60,048,502...60,050,447
Ensembl chr 4:59,941,517...60,050,298
G
ALB
albumin
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:35999755
NCBI chr13:62,133,747...62,169,349
Ensembl chr13:62,053,814...62,294,709
G
ALOX12
arachidonate 12-lipoxygenase, 12S type
ISO
protein:increased expression:large intestine epithelium
RGD
PMID:7679252
RGD:5509621
NCBI chr 5:32,026,193...32,038,698
Ensembl chr 5:31,882,501...32,038,119
G
ALPI
alkaline phosphatase, intestinal
ISO
protein:decreased expression:colonic mucosa
RGD
PMID:22783049
RGD:14367879
NCBI chr25:44,107,418...44,110,947
G
APLN
apelin
ISO
protein:increased expression:intestine
RGD
PMID:17391779
RGD:1626177
NCBI chr X:100,863,360...100,873,105
G
APOA4
apolipoprotein A4
severity
ISO
DNA:missense mutation:cds:p.Q360H (human) CTD Direct Evidence: marker/mechanism
RGD CTD
PMID:17206692 PMID:35999755
RGD:5685660
NCBI chr 5:16,751,588...16,754,215
Ensembl chr 5:16,751,799...16,754,837
G
AQP7
aquaporin 7
severity
ISO
mRNA, protein:decreased expression:colon
RGD
PMID:15338270
RGD:1626292
NCBI chr11:50,474,007...50,488,191
G
ARPC2
actin related protein 2/3 complex subunit 2
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:18836448
NCBI chr37:24,914,389...24,935,998
Ensembl chr37:24,914,642...24,935,824
G
BRINP3
BMP/retinoic acid inducible neural specific 3
ISO
mRNA,protein:decreased expression:intestine
RGD
PMID:25171508
RGD:14398484
NCBI chr38:8,181,227...8,558,518
Ensembl chr38:8,205,916...8,558,482
G
BTNL2
butyrophilin like 2
susceptibility
ISO
DNA:SNPs: : rs2294881,rs9268480,rs2076523(human)
RGD
PMID:19659809
RGD:9685032
NCBI chr12:2,085,589...2,106,787
Ensembl chr12:2,086,324...2,107,124
G
C3
complement C3
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:35999755
NCBI chr20:53,566,226...53,598,365
Ensembl chr20:53,566,261...53,598,761
G
CARD9
caspase recruitment domain family member 9
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:20228799
NCBI chr 9:49,110,913...49,120,758
Ensembl chr 9:49,113,923...49,120,591
G
CASP3
caspase 3
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:24055189
NCBI chr16:45,920,074...45,940,507
Ensembl chr16:45,920,071...45,940,505
G
CCL20
C-C motif chemokine ligand 20
treatment
ISO
CTD Direct Evidence: marker/mechanism
RGD CTD
PMID:16306769 PMID:21887805
RGD:7488892
NCBI chr25:40,506,385...40,509,903
Ensembl chr25:40,506,753...40,509,709
G
CCL7
C-C motif chemokine ligand 7
ISO
protein:increased expression:colon
RGD
PMID:10433925
RGD:6483784
NCBI chr 9:38,994,638...38,996,103
Ensembl chr 9:38,993,911...39,010,483
G
CCNY
cyclin Y
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:18438405
NCBI chr 2:1,387,962...1,720,497
Ensembl chr 2:1,390,082...1,720,357
G
CCR3
C-C motif chemokine receptor 3
ISO
RGD
PMID:21077277
RGD:6892920
NCBI chr20:42,382,380...42,398,449
Ensembl chr20:42,383,135...42,384,217
G
CCR6
C-C motif chemokine receptor 6
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:16306769
NCBI chr 1:54,932,798...54,960,646
Ensembl chr 1:54,932,690...54,959,740
G
CD40
CD40 molecule
ISO
protein:increased expression:intestine, epithelial cell
RGD
PMID:20133813
RGD:5490590
NCBI chr24:33,352,992...33,383,488
Ensembl chr24:33,372,930...33,383,301
G
CDH1
cadherin 1
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:19915572
NCBI chr 5:80,757,508...80,834,878
Ensembl chr 5:80,757,508...80,834,878
G
CDH3
cadherin 3
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:19915572
NCBI chr 5:80,864,859...80,912,136
Ensembl chr 5:80,863,661...80,913,019
G
CDKN1A
cyclin dependent kinase inhibitor 1A
disease_progression
ISO
RGD
PMID:15743319
RGD:8662406
NCBI chr12:5,746,898...5,755,103
Ensembl chr12:5,745,852...5,892,281
G
CFB
complement factor B
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:35999755
NCBI chr12:1,400,143...1,406,267
G
CHRNA7
cholinergic receptor nicotinic alpha 7 subunit
ISO
mRNA:increased expression:intestine:
RGD
PMID:27051591
RGD:151667910
NCBI chr 3:36,852,082...37,164,930
Ensembl chr 3:36,852,543...36,978,399
G
COL18A1
collagen type XVIII alpha 1 chain
ISO
Protein:increased expression:large intestine mucosa
RGD
PMID:17011522
RGD:1600887
NCBI chr31:38,915,872...38,957,484
G
COL1A1
collagen type I alpha 1 chain
ISO
RGD
PMID:17939044
RGD:5688304
NCBI chr 9:26,183,852...26,199,927
Ensembl chr 9:26,183,852...26,199,927
G
COL6A3
collagen type VI alpha 3 chain
ISO
protein:increased expression:serum (human)
RGD
PMID:32245981
RGD:401900121
NCBI chr25:47,971,439...48,052,673
Ensembl chr25:47,971,315...48,052,402
G
CXCL8
C-X-C motif chemokine ligand 8
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:12133438 PMID:15955209
NCBI chr13:62,435,035...62,438,354
Ensembl chr13:62,434,422...62,438,354
G
CXCR2
C-X-C motif chemokine receptor 2
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:21297633
NCBI chr37:24,831,351...24,846,387
Ensembl chr37:24,843,171...24,844,247
G
CXCR3
C-X-C motif chemokine receptor 3
ISO
mRNA:increased expression:peripheral blood immature plasma cells
RGD
PMID:21087446
RGD:6480657
NCBI chr X:55,882,433...55,884,582
Ensembl chr X:55,882,433...55,884,582
G
CXCR4
C-X-C motif chemokine receptor 4
ISO
mRNA:increased expression:peripheral blood immature plasma cells
RGD
PMID:21087446
RGD:6480657
NCBI chr19:38,874,650...38,877,740
Ensembl chr19:38,874,145...38,877,740
G
CYP24A1
cytochrome P450 family 24 subfamily A member 1
susceptibility
ISO
DNA:SNPs:multiple (human)
RGD
PMID:28811712
RGD:151665177
NCBI chr24:39,861,018...39,878,161
Ensembl chr24:39,862,355...39,878,216
G
DAP
death associated protein
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:21297633
NCBI chr34:3,616,960...3,682,424
Ensembl chr34:3,617,000...3,680,793
G
DLA-DQB1
major histocompatibility complex, class II, DQ beta 1
ISO
RGD
PMID:31038770
RGD:14865009
NCBI chr12:2,305,307...2,307,711
G
DPEP1
dipeptidase 1
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:35999755
NCBI chr 5:63,909,034...63,923,309
Ensembl chr 5:63,909,042...63,923,492
G
DUOX2
dual oxidase 2
ISO
mRNA:increased expression:colon (human)
RGD
PMID:19759286
RGD:40924645
NCBI chr30:11,521,833...11,541,719
Ensembl chr30:11,521,845...11,541,716
G
ECM1
extracellular matrix protein 1
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:18438406
NCBI chr17:59,696,125...59,701,990
Ensembl chr17:59,696,477...59,701,744
G
EPHB2
EPH receptor B2
ameliorates
ISO
RGD
PMID:33722292
RGD:127285641
NCBI chr 2:76,427,112...76,551,494
Ensembl chr 2:76,428,203...76,612,786
G
ESR2
estrogen receptor 2
ISO
mRNA:decreased expression:colon
RGD
PMID:21252046
RGD:5508810
NCBI chr 8:38,645,917...38,715,347
Ensembl chr 8:38,645,430...38,702,691
G
F2
coagulation factor II, thrombin
ISO
RGD
PMID:21593018
RGD:5147754
NCBI chr18:42,782,744...42,799,531
Ensembl chr18:42,782,751...42,799,459
G
FAS
Fas cell surface death receptor
treatment
ISO
RGD
PMID:30122878
RGD:13792562
NCBI chr26:38,738,811...38,763,298
Ensembl chr26:38,737,611...38,763,321
G
FASLG
Fas ligand
treatment
ISO
RGD
PMID:30122878
RGD:13792562
NCBI chr 7:26,335,837...26,344,224
Ensembl chr 7:26,335,846...26,344,224
G
FGF7
fibroblast growth factor 7
ISO
mRNA:increased expression:colon, lamina propria, myofibroblasts (human)
RGD
PMID:9358773
RGD:126928145
NCBI chr30:15,555,016...15,608,230
Ensembl chr30:15,555,266...15,606,521
G
GC
GC vitamin D binding protein
susceptibility
ISO
DNA:polymorphism:cds:p.T420K(human)
RGD
PMID:21832969
RGD:5509866
NCBI chr13:60,795,305...60,828,038
Ensembl chr13:60,795,305...60,827,929
G
GHRL
ghrelin and obestatin prepropeptide
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:19617644
NCBI chr20:8,092,921...8,097,512
Ensembl chr20:8,092,957...8,097,510
G
GNA12
G protein subunit alpha 12
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:21297633
NCBI chr 6:14,375,144...14,476,018
Ensembl chr 6:14,413,576...14,473,764
G
GPR65
G protein-coupled receptor 65
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:30616622
NCBI chr 8:59,334,544...59,351,039
Ensembl chr 8:59,349,839...59,350,864
G
GPX1
glutathione peroxidase 1
ISO
protein:decreased expression:erythrocyte
RGD
PMID:20186929
RGD:11352754
NCBI chr20:39,889,165...39,890,253
Ensembl chr20:39,889,174...39,890,260
G
GPX2
glutathione peroxidase 2
disease_progression
ISO
protein:increased expression:large intestine (human)
RGD
PMID:18479189
RGD:152998902
NCBI chr 8:39,322,040...39,325,833
Ensembl chr 8:39,322,034...39,325,817
G
HERC2
HECT and RLD domain containing E3 ubiquitin protein ligase 2
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:18438405
NCBI chr 3:31,723,113...31,966,061
Ensembl chr 3:31,723,500...31,966,199
G
HLA-DRB1
MHC class II DLA DRB1 beta chain
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:25559196
NCBI chr12:2,151,409...2,164,564
G
HNF4A
hepatocyte nuclear factor 4 alpha
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:19915572
NCBI chr24:31,847,864...31,908,337
Ensembl chr24:31,847,961...31,905,916
G
HNMT
histamine N-methyltransferase
ISO
RGD
PMID:18340362
RGD:5509777
NCBI chr19:40,656,266...40,702,498
Ensembl chr19:40,655,161...40,702,218
G
HSPA4
heat shock protein family A (Hsp70) member 4
ISO
protein:increased expression:colon mucosa, epithelium (human)
RGD
PMID:22297444
RGD:5688753
NCBI chr11:21,290,603...21,363,701
Ensembl chr11:21,290,621...21,505,122
G
HTRA1
HtrA serine peptidase 1
ISO
protein:decreased expression:colonic epithelium,colonic mucosa (human)
RGD
PMID:28586045
RGD:152985530
NCBI chr28:32,133,779...32,157,835
Ensembl chr28:32,132,547...32,157,409
G
ICAM1
intercellular adhesion molecule 1
ISO
mRNA:increased expression:substantia nigra (rat) CTD Direct Evidence: marker/mechanism
RGD CTD
PMID:15553846 PMID:20584104
RGD:4145388
NCBI chr20:50,818,715...50,827,914
Ensembl chr20:50,818,715...50,827,914
G
ICOSLG
inducible T cell costimulator ligand
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:20228799
NCBI chr31:38,084,861...38,094,743
G
IGF1R
insulin like growth factor 1 receptor
ISO
protein:altered expression:colon
RGD
PMID:18938767
RGD:5686432
NCBI chr 3:41,795,337...42,096,255
Ensembl chr 3:41,794,623...42,090,387
G
IGF2
insulin like growth factor 2
disease_progression
ISO
RGD
PMID:16088202
RGD:5509966
NCBI chr18:46,294,036...46,311,982
Ensembl chr18:46,294,019...46,311,982
G
IKZF1
IKAROS family zinc finger 1
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:20228799
NCBI chr18:1,661,851...1,750,987
Ensembl chr18:1,661,690...1,770,768
G
IL10
interleukin 10
ISO
CTD Direct Evidence: marker/mechanism
CTD RGD
PMID:18836448 PMID:20228799 PMID:26660358 PMID:28120341
RGD:14975153 RGD:14975255
NCBI chr 7:5,933,285...5,937,057
Ensembl chr 7:5,933,285...5,937,057
G
IL12B
interleukin 12B
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:18438406 PMID:20228799 PMID:21297633
NCBI chr 4:51,178,637...51,194,606
Ensembl chr 4:51,183,568...51,193,228
G
IL17REL
interleukin 17 receptor E like
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:20228798
NCBI chr10:17,238,418...17,242,686
Ensembl chr10:17,216,084...17,242,226
G
IL18RAP
interleukin 18 receptor accessory protein
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:20228799
NCBI chr10:40,578,503...40,605,800
Ensembl chr10:40,581,096...40,605,766
G
IL1B
interleukin 1 beta
ISO
protein:increased expression:lung CTD Direct Evidence: marker/mechanism
RGD CTD
PMID:12133438 PMID:15955209 PMID:20452301 PMID:22119283 PMID:24812904
RGD:10450593
NCBI chr17:37,019,329...37,033,388
Ensembl chr17:37,019,329...37,024,458
G
IL1R2
interleukin 1 receptor type 2
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:21297633
NCBI chr10:40,967,532...41,003,659
Ensembl chr10:40,896,669...41,034,113
G
IL1RN
interleukin 1 receptor antagonist
ISO
DNA:repeats:intron:IVS2+914_1000dup IL1RN*2 (human)
RGD
PMID:8119534
RGD:6909136
NCBI chr17:37,236,690...37,250,424
Ensembl chr17:37,212,751...37,249,329
G
IL23R
interleukin 23 receptor
ISO
DNA:SNP,Haplotype: :rs1884444(human) CTD Direct Evidence: marker/mechanism
RGD CTD
PMID:18438406 PMID:19122664 PMID:20228799 PMID:23093364
RGD:8549574
NCBI chr 5:43,307,422...43,369,806
Ensembl chr 5:43,308,982...43,368,474
G
IL33
interleukin 33
severity treatment
ISO
mRNA:increased expression:sigmoid colon
RGD
PMID:21037074 PMID:25112700 PMID:28802904
RGD:39938951 RGD:39938966 RGD:40813742
NCBI chr11:27,219,878...27,256,723
Ensembl chr11:27,219,878...27,256,721
G
IL7R
interleukin 7 receptor
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:21297633
NCBI chr 4:72,633,528...72,668,242
Ensembl chr 4:72,636,325...72,668,300
G
IRF5
interferon regulatory factor 5
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:21297633
NCBI chr14:7,724,168...7,734,976
Ensembl chr14:7,724,780...7,742,795
G
JAK2
Janus kinase 2
ISO
CTD Direct Evidence: marker/mechanism DNA:SNP: :rs10758669 (human)
CTD RGD
PMID:20228799 PMID:21297633 PMID:22269120
RGD:6483020
NCBI chr 1:93,321,055...93,438,898
Ensembl chr 1:93,142,635...93,435,997
G
KDR
kinase insert domain receptor
ISO
protein:increased expression:colon
RGD
PMID:19013462
RGD:5684406
NCBI chr13:47,442,861...47,484,574
Ensembl chr13:47,442,764...47,485,042
G
KIF21B
kinesin family member 21B
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:20228799
NCBI chr 7:2,185,040...2,231,046
Ensembl chr 7:2,184,733...2,231,058
G
LAMB1
laminin subunit beta 1
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:19915572
NCBI chr18:12,634,640...12,700,311
Ensembl chr18:12,630,554...12,700,308
G
LOC481473
immunity-related GTPase family M protein
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:20228799
NCBI chr11:793,416...795,373
Ensembl chr11:793,424...794,617
G
LSP1
lymphocyte specific protein 1
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:21297633
NCBI chr18:46,087,886...46,127,307
Ensembl chr18:46,087,922...46,127,263
G
LTF
lactotransferrin
ISO
CTD Direct Evidence: marker/mechanism|therapeutic
CTD
PMID:16640825 PMID:35999755
NCBI chr20:42,231,994...42,263,202
Ensembl chr20:42,231,994...42,263,202
G
MASP2
MBL associated serine protease 2
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:12904520
NCBI chr 2:84,976,366...84,987,376
Ensembl chr 2:84,976,456...84,989,797
G
MIR155
microRNA mir-155
ISO
miRNA:decreased expression:feces miRNA:increased expression:colon
RGD
PMID:29325325 PMID:29438285 PMID:29668922 PMID:30927737
RGD:21079443 RGD:21403682 RGD:24922207 RGD:24922213
NCBI chr31:21,078,768...21,078,828
Ensembl chr31:21,078,758...21,078,833
G
MIR31
microRNA mir-31
ISO
miRNA:increased expression:colon
RGD
PMID:29438285
RGD:21403682
NCBI chr11:40,904,438...40,904,496
Ensembl chr11:40,904,437...40,904,503
G
MMP1
matrix metallopeptidase 1
ISO
RGD
PMID:18837084
RGD:7207395
NCBI chr 5:28,978,385...28,986,644
Ensembl chr 5:28,978,473...28,986,648
G
MMP9
matrix metallopeptidase 9
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:22119283
NCBI chr24:33,274,260...33,281,116
Ensembl chr24:33,274,268...33,281,293
G
MPO
myeloperoxidase
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:20380826 PMID:22119283 PMID:24055189
NCBI chr 9:32,927,483...32,938,007
Ensembl chr 9:32,927,483...32,937,820
G
MST1
macrophage stimulating 1
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:18438406 PMID:20228799
NCBI chr20:39,582,237...39,586,958
Ensembl chr20:39,582,282...39,586,908
G
MTRR
5-methyltetrahydrofolate-homocysteine methyltransferase reductase
susceptibility
ISO
DNA:polymorphism: :66A>G (human)
RGD
PMID:21947961
RGD:5508217
NCBI chr34:6,068,572...6,119,580
Ensembl chr34:6,070,046...6,098,312
G
MUC2
mucin 2, oligomeric mucus/gel-forming
ISO
mRNA:altered expression: :
RGD
PMID:12870797
RGD:2324685
NCBI chr18:45,416,347...45,438,226
G
NKX2-3
NK2 homeobox 3
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:18438405 PMID:18438406 PMID:20228799
NCBI chr28:12,466,319...12,469,467
Ensembl chr28:12,466,368...12,469,473
G
NOD2
nucleotide binding oligomerization domain containing 2
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:20452301
NCBI chr 2:64,636,850...64,667,232
Ensembl chr 2:64,635,519...64,667,232
G
ORMDL3
ORMDL sphingolipid biosynthesis regulator 3
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:20228799
NCBI chr 9:22,594,425...22,601,108
Ensembl chr 9:22,594,480...22,599,999
G
PON1
paraoxonase 1
ISO
mRNA:decreased expression:colon
RGD
PMID:17664137
RGD:5509924
NCBI chr14:20,565,620...20,600,774
Ensembl chr14:20,565,641...20,642,985
G
PON3
paraoxonase 3
ISO
mRNA:decreased expression:colon
RGD
PMID:17664137
RGD:5509924
NCBI chr14:20,615,180...20,642,807
Ensembl chr14:20,565,641...20,642,985
G
PRDM1
PR/SET domain 1
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:21297633
NCBI chr12:63,454,242...63,495,278
Ensembl chr12:63,470,974...63,495,579
G
PSMG1
proteasome assembly chaperone 1
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:20228799
NCBI chr31:33,914,640...33,925,925
Ensembl chr31:33,914,668...33,925,883
G
PTGER4
prostaglandin E receptor 4
ISO
RGD
PMID:21818367
RGD:6483532
NCBI chr 4:68,663,362...68,676,241
Ensembl chr 4:68,663,364...68,676,358
G
PTGS1
prostaglandin-endoperoxide synthase 1
ISO
RGD
PMID:17429720
RGD:2300267
NCBI chr 9:60,195,118...60,216,847
Ensembl chr 9:60,195,124...60,216,819
G
PTGS2
prostaglandin-endoperoxide synthase 2
ISO
RGD
PMID:17429720
RGD:2300267
NCBI chr 7:19,668,079...19,674,903
Ensembl chr 7:19,668,082...19,674,903
G
PTPN2
protein tyrosine phosphatase non-receptor type 2
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:18438405
NCBI chr 7:78,160,564...78,252,382
Ensembl chr 7:78,160,589...78,252,719
G
RELA
RELA proto-oncogene, NF-kB subunit
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:15955209
NCBI chr18:51,550,003...51,558,861
Ensembl chr18:51,550,040...51,558,875
G
RIPK2
receptor interacting serine/threonine kinase 2
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:20452301
NCBI chr29:35,283,209...35,311,608
Ensembl chr29:35,282,072...35,311,333
G
SELL
selectin L
ISO
DNA:polymorphism: :p.F206L (human)
RGD
PMID:19212205
RGD:13464267
NCBI chr 7:28,906,752...28,927,959
Ensembl chr 7:28,906,809...29,094,008
G
SELP
selectin P
ISO
protein:increased expression:serum
RGD
PMID:21526498
RGD:6218993
NCBI chr 7:28,956,428...28,997,266
Ensembl chr 7:28,958,486...28,996,313
G
SLC11A1
solute carrier family 11 member 1
ISO
CTD Direct Evidence: marker/mechanism DNA:transition, repeat:promoter:-237C>T (human) DNA:polymorphism:promoter (human)
CTD RGD
PMID:11929588 PMID:16059695 PMID:18340647
RGD:5684939 RGD:5684968
NCBI chr37:25,039,203...25,047,461
Ensembl chr37:25,038,360...25,047,282
G
SLC26A3
solute carrier family 26 member 3
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:19915573
NCBI chr18:12,817,177...12,843,502
Ensembl chr18:12,808,806...12,843,076
G
SPHK1
sphingosine kinase 1
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:24055189
NCBI chr 9:4,311,698...4,314,773
Ensembl chr 9:4,311,683...4,314,483
G
STAT3
signal transducer and activator of transcription 3
ISO
CTD Direct Evidence: marker/mechanism DNA:SNP: :rs744166 (human)
CTD RGD
PMID:18438405 PMID:20228799 PMID:22269120
RGD:6483020
NCBI chr 9:20,539,660...20,614,631
Ensembl chr 9:20,539,697...20,612,672
G
THBD
thrombomodulin
ISO
protein:decreased expression:colon, blood vessel
RGD
PMID:17557119
RGD:5685011
NCBI chr24:599,773...601,649
Ensembl chr24:599,773...601,649
G
TNF
tumor necrosis factor
treatment
ISO
protein:increased expression:lung CTD Direct Evidence: marker/mechanism
RGD CTD
PMID:19617644 PMID:20452301 PMID:22119283 PMID:24812904 PMID:25204186 PMID:28120341 More...
RGD:10450577 RGD:10450593 RGD:14975153
NCBI chr12:1,074,561...1,076,425
Ensembl chr12:1,074,552...1,076,425
G
TNFAIP3
TNF alpha induced protein 3
severity
ISO
mRNA,protein:increased expression, decreased expression:colonic mucosa (human)
RGD
PMID:28842689
RGD:151347619
NCBI chr 1:30,247,432...30,262,992
Ensembl chr 1:30,251,059...30,261,001
G
TNFSF15
TNF superfamily member 15
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:20228799
NCBI chr11:68,887,858...68,909,406
Ensembl chr11:68,893,084...68,909,602
G
VCAM1
vascular cell adhesion molecule 1
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:15553846
NCBI chr 6:49,341,669...49,359,841
Ensembl chr 6:49,342,151...49,359,933
G
VEGFA
vascular endothelial growth factor A
ISO
protein:increased expression:colon, plasma
RGD
PMID:19013462
RGD:5684406
NCBI chr12:12,209,032...12,224,978
Ensembl chr12:12,208,231...12,224,965
G
VIP
vasoactive intestinal peptide
severity
ISO
mRNA:decreased expression:colon
RGD
PMID:22143367
RGD:5685619
NCBI chr 1:42,941,655...42,950,160
Ensembl chr 1:42,941,224...42,950,700
G
VIPR1
vasoactive intestinal peptide receptor 1
ISO
RGD
PMID:17611633
RGD:5685618
NCBI chr23:11,635,809...11,666,926
Ensembl chr23:11,635,394...11,666,936
Term paths to the root one shortest all shortest one longest all longest one shortest and longest all